Theramed Corporation Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh Medical
Published: Apr 15, 2011
Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
MISSISSAUGA, Ontario, April 14, 2011
MISSISSAUGA, Ontario, April 14, 2011 /PRNewswire/ -- Theramed Corporation ("Theramed") announces that it has obtained the exclusive distribution rights in Canada for the EBB® Complete Tamponade System and the JETTY® Vaginal Repair Balloon, two newly developed medical devices used to advance the practice of obstetrics, from Glenveigh International, LLC ("Glenveigh"). [Both] medical device products have been approved for sale by Health Canada, and Theramed will begin distributing these products immediately.
About the EBB® Complete Tamponade System
EBB® is a complete tamponade solution for the emergency of postpartum hemorrhage. Designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy, the EBB® balloon is made of a malleable yet extremely strong material, allowing EBB to expand and conform to any uterine shape. Ebb also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.
About the JETTY® Vaginal Repair Balloon
JETTY® is indicated for use during episiotomy and vaginal laceration repair to temporarily prevent the postpartum discharge of fluids from the vagina in order to assist with the repair procedure. JETTY® provides clarity and cleanliness for a timely, effective repair, and it eliminates the need for vaginal packing with gauze or sponges.
About Theramed Corporation
Theramed Corporation, headquartered in Mississauga, Ontario, is a specialty pharmaceutical company, focused on the development, acquisition, in-licensing, marketing, and distribution of medical products in Canada. The Company is dedicated to bringing new-to-market and well-established healthcare innovations to Canadian Physicians and Hospitals, be these Pharmaceuticals, Biotech products, or Medical Devices. The company currently markets Delatestryl®, Viroptic®, CollatampG® and FSME IMMUNE®.
About Glenveigh International, LLC
Glenveigh International is the subsidiary of Glenveigh Medical LLC responsible for its ex-U.S. business. Glenveigh is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.
SOURCE Theramed Corporation